THE TAPE

Erasca, Inc. Common Stock

$15.11▼ −3.51%
Last close
Relative strength
99RS
of 99, against every stock▲ +1 on the month
Powering up
Unconfirmed
+32.5%
six months against Pharmaceutical Preparations
52-week range
−37.8%
from the high
$2.50$24.28
Setup
blue skyplayed out
−7.9%
against the pivot at $16.41
No report date on the calendar.
No US GAAP filings to read.
11/16 O 15.49 H 15.84 L 14.87 Vol 5.8M
Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

The four are not in order. That is a description of where the averages sit, not a view about what happens next.

RS99
vs pivot−7.89%
Tightening1.05×
Dry-up0.87×
Up/down vol-0.05
From high38%
played out3 of 9checks
Previous breakout trailed out ▲ +91.49% in Jan
Powering up
Support and resistance
Support below
$15.02
-0.6% · tested 9× · last 12 sessions ago
Resistance above
$15.91
+5.3% · tested 3× · last 26 sessions ago

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

The base has run 3.2 weeks and fell 21% from its ceiling at its deepest. The pivot is $16.41, and the stock closed 7.9% below it. Its relative strength rating is 99.

Against its industry
UnconfirmedNone of the patterns above holds.
One month against its industry
+8.0%
Three months against its industry
-3.5%
Six months against its industry
+32.5%

Read against an equal-weighted index of Pharmaceutical Preparations, which is +10.9% against the S&P 500 over six months Partly aligned.

Also on
Peers
Catalyst roadmap

Nothing dated in the next three months that we can ingest automatically.

How it moves on earnings

On average 6.6% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business

No figures in US GAAP filings for this company. Most foreign listings report under international standards, which this does not read.

Tracked funds

Held by 1 of 46 tracked funds at the end of Q3 2026.

Last quarter: 1 bought new.

Checking your subscription…

From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.

Flagged by the market sweep
Closed above its 20- and 50-day on heavy volumeTape · 2026-11-14
above 20d & 50d on 1.6x volume at 15.66
Mixed: stocks have outrun random stocks by 0.2% over three sessions, not consistently enough to call (1,668 cases over 60 nights). Against their own sector they have lagged by 0.7%.
Reported resultsFiling · 2026-11-13
2.02
No measurable effect: stocks behave like random ones over the next three sessions (2,340 cases over 54 nights).
GappedTape · 2026-11-13
-6.1%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Moved 5%+ down on earningsTape · 2026-11-13
-6.1% on earnings 2026-11-11
No measurable effect: stocks behave like random ones over the next three sessions (665 cases over 44 nights).
Closed above its 20- and 50-day on heavy volumeTape · 2026-11-12
above 20d & 50d on 2.8x volume at 16.80
Mixed: stocks have outrun random stocks by 0.2% over three sessions, not consistently enough to call (1,668 cases over 60 nights). Against their own sector they have lagged by 0.7%.
GappedTape · 2026-11-12
+8.5%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Moved 5%+ up on earningsTape · 2026-11-12
+8.5% on earnings 2026-11-10
No measurable effect: stocks behave like random ones over the next three sessions (604 cases over 42 nights).
Unusual volumeTape · 2026-11-12
4.8 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

The geometry
falling wedge
Level · ceiling$14.33
Wrong below$12.83
Measured target · the shape's own height$16.42
Reward against risk1.4×
Lines closed · of the gap they started with6%
Through to the apex45%
Touches · swing points the lines are drawn through17 up · 17 down
Length12.2 weeks
squeeze
Level · ceiling$15.70
Wrong below$12.82
Measured target · a squeeze has no height to projectnone
Leaning · and strengtheningup
Length3.2 weeks

Leaning is where price has been sitting against its own range while the range was quiet. It is not a forecast of which way the range opens up, and this site has no measurement that would support one.

What lines up

3 of 9 published checks currently line up. This is a count, not a probability — nothing on this site measures how often a setup works.

Relative strength of 80 or better
Above its 50-day line
Above its 200-day line
Averages fully stacked
Within 5% of its pivot
Range tightening through the base
Volume drying up through the base
More up-volume than down-volume
Within 15% of its 52-week high
What analysts expect
Strong buy2
Buy5
Hold2
Sell0
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

Checking your subscription…

X-ray
3w · 21%

The most recent of 3 completed bases.

Checking your subscription…

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Erasca, Inc. Common Stock (ERAS) — The Tape